Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-15-066810
Filing Date
2015-11-18
Accepted
2015-11-18 19:32:25
Documents
1
Period of Report
2015-11-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v425169_3a.html 3/A  
1 OWNERSHIP DOCUMENT v425169_3a.xml 3/A 5249
  Complete submission text file 0001144204-15-066810.txt   7107
Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 379 WEST BROADWAY NEW YORK NY 10012
Business Address 379 WEST BROADWAY NEW YORK NY 10012 212-404-6677
Anthion Partners II LLC (Reporting) CIK: 0001658549 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-35798 | Film No.: 151241978

Mailing Address 379 WEST BROADWAY NEW YORK NY 10021
Business Address
Moradi David (Reporting) CIK: 0001658843 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-35798 | Film No.: 151241977